Patents by Inventor Eric Wang

Eric Wang has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 12290163
    Abstract: A configurable, wearable electronic device is shown and described. The configurable, wearable electronic device may be configured to be worn around a user's neck via a lanyard and a special longitudinal insert of the configurable having an attached tether, worn on a user's clothing via a conforming cradle assembly or worn on a user's wrist by removing one or more longitudinal inserts of the configurable, wearable electronic device and connecting a wrist strap having two longitudinal inserts that fit into a respective channel of the configurable, wearable electronic device.
    Type: Grant
    Filed: September 26, 2022
    Date of Patent: May 6, 2025
    Assignee: Universal Electronics Inc.
    Inventor: Eric Wang
  • Patent number: 12279294
    Abstract: A method performed by a network node (260, 800) is disclosed. The network node determines (701), based on one or more quality-of-service (QoS) parameters, an aggregated uplink (UL) scheduling pattern for a wireless device (210, 1000, 1100), the aggregated UL scheduling pattern for the wireless device comprising UL resources from a plurality of carriers. The one or more QoS parameters indicate one or more QoS requirements associated with a service. At least one of the one or more QoS parameters indicates a delay requirement 0 associated with the service.
    Type: Grant
    Filed: September 24, 2020
    Date of Patent: April 15, 2025
    Assignee: TELEFONAKTIEBOLAGET LM ERICSSON (PUBL)
    Inventors: Ying Sun, Yi-Pin Eric Wang, Yutao Sui
  • Patent number: 12250661
    Abstract: There is provided a method performed by a wireless device for communicating with a network node in a wireless communication network. The method includes using a field in a Master Information Block (MIB) received by the wireless device, as an indication of a presence of an extended MIB (eMIB) and identifying which candidate resource of at least one candidate resource that contains the eMIB based on the indication of the presence of the eMIB. There is also provided a corresponding wireless device for communicating with a network node, a method perform by a network node, and a network node.
    Type: Grant
    Filed: November 6, 2020
    Date of Patent: March 11, 2025
    Assignee: Telefonaktiebolaget LM Ericsson (Publ)
    Inventors: Yi-Pin Eric Wang, Xingqin Lin, Yutao Sui, Mohammad Mozaffari, Andreas Höglund, Olof Liberg, Luca Feltrin
  • Patent number: 12237633
    Abstract: A connector comprises a housing including an upper casing defining an aperture through which a wire is adapted to extend, and a lower casing defining a chamber receiving the upper casing. The chamber defines an opening that opens toward the upper casing. The upper casing is movable relative to the lower casing upon the exerting of a force on the upper casing such that the aperture and the opening at least partially overlap. A conductive terminal is disposed in the chamber of the lower casing and is adapted to tear an outer insulation of the wire arranged within the chamber to electrically connect to a conductor of the wire as the upper casing is moved toward the lower casing.
    Type: Grant
    Filed: August 4, 2022
    Date of Patent: February 25, 2025
    Assignee: Tyco Electronics (Shanghai) Co., Ltd.
    Inventors: Yang (Leon) Zou, Liming (Eric) Wang, Xinxin (Daisy) Li, Zebin (Donnie) Tang, Feng (Will) Chen
  • Patent number: 12227488
    Abstract: Disclosed are compounds and pharmaceutically acceptable salts and stereoisomers thereof that may cause degradation of various proteins e.g., IKZF2 (Helios). Also disclosed are pharmaceutical compositions containing same, and methods of making and using the compounds to treat diseases and disorders characterized or mediated by aberrant protein activity.
    Type: Grant
    Filed: December 3, 2019
    Date of Patent: February 18, 2025
    Assignee: DANA-FARBER CANCER INSTITUTE, INC.
    Inventors: Alyssa Verano, Eric Wang, Radoslaw Nowak, Jing Ting Christine Yuan, Nathanael Gray, Eric Fischer, Tinghu Zhang, Hu Liu
  • Publication number: 20250051131
    Abstract: A device for an elevator system has a blocking arrangement and a measuring arrangement, wherein the blocking arrangement connects a counterweight and/or a car of the elevator system to a rail system of the elevator system, and wherein the measuring arrangement maps a force transferred from the counterweight and/or car into the rail system as a force value.
    Type: Application
    Filed: December 19, 2022
    Publication date: February 13, 2025
    Inventors: Romeo Lo Jacono, Gilles Trottman, Eric Wang
  • Publication number: 20250025074
    Abstract: Disclosed and described herein are systems, methods and device for providing simultaneous non-invasive arterial and venous oxygen saturation. An ultra-thin and self-adherable optical electronic tattoo measures blood absorbance changes from multiple locations. Another sensor may be included to provide self-calibration. Using algorithms, the signals from the blood from the artery and vein can be better separated and yield accurate blood oxygen assessments.
    Type: Application
    Filed: July 16, 2024
    Publication date: January 23, 2025
    Inventors: Nanshu Lu, Philip Tan, Eric Wang, Sarnab Bhattacharya
  • Patent number: 12195799
    Abstract: The present invention provides processes for determining accurate risk probabilities for fetal aneuploidies. Specifically, the invention provides non-invasive evaluation of genomic variations through chromosome-selective sequencing and non-host fraction data analysis of maternal samples.
    Type: Grant
    Filed: June 29, 2020
    Date of Patent: January 14, 2025
    Assignee: Ariosa Diagnostics, Inc.
    Inventors: Arnold Oliphant, Andrew Sparks, Eric Wang, Craig Struble
  • Patent number: 12189499
    Abstract: Examples of systems described herein provide for share-level disaster recovery on, for example, virtualized file servers by enabling additional snapshots, including self-service recovery (SSR) snapshot migration in addition to replication snapshot migration to a disaster recovery location. In examples, a disaster recovery location may receive a replication of a share of a file system, the snapshot configured for recovery of the share at the disaster recovery location. The replication snapshot may include one or more additional snapshots, each taken since a time of a previous replication snapshot. At least one of the one or more additional snapshots may include an SSR snapshot, identifiable based at least on a tag associated with a process used to create the SSR snapshot at a primary location. The at least one additional snapshot may be extracted for use by another instance of the process at the disaster recovery location.
    Type: Grant
    Filed: July 29, 2022
    Date of Patent: January 7, 2025
    Assignee: Nutanix, Inc.
    Inventors: Eric Wang, Kalpesh Ashok Bafna
  • Publication number: 20240425547
    Abstract: Compounds for targeting and agents for imaging, prostate-specific membrane antigen (PSMA) are disclosed. Methods of synthesizing compounds and imaging agents, as well as methods for imaging PSMA are also disclosed. The imaging agents disclosed are suitable for PET and SPECT imaging.
    Type: Application
    Filed: August 20, 2024
    Publication date: December 26, 2024
    Inventors: Eric Wang, Hartmuth C. Kolb, Anna Katrin Szardenings, Changhui Liu, Joseph C. Walsh, Gang Chen, Anjana Sinha, Dhanalakshmi Kasi, Chul Yu, Umesh B. Gangadharmath, Wei Zhang, Tieming Zhao, Vani P. Mocharla
  • Publication number: 20240409580
    Abstract: Compounds for targeting and agents for imaging, prostate-specific membrane antigen (PSMA) are disclosed. Methods of synthesizing compounds and imaging agents, as well as methods for imaging PSMA are also disclosed. The imaging agents disclosed are suitable for PET and SPECT imaging.
    Type: Application
    Filed: August 20, 2024
    Publication date: December 12, 2024
    Inventors: Eric Wang, Hartmuth C. Kolb, Anna Katrin Szardenings, Changhui Liu, Joseph C. Walsh, Gang Chen, Anjana Sinha, Dhanalakshmi Kasi, Chul Yu, Umesh B. Gangadharmath, Wei Zhang, Tieming Zhao, Vani P. Mocharla
  • Patent number: 12166715
    Abstract: A network node configured to, and/or comprising a radio interface and/or comprising processing circuitry configured to transmit a synchronization block mapped to four OFDM symbols in the time domain and 144 contiguous subcarriers in the frequency domain is provided. Optionally, a first of the four OFDM symbol is used by a primary synchronization signal, PSS. Optionally, a third of the four OFDM symbols is used by a secondary synchronization signal, SSS. Optionally, a second and a fourth of the OFDM symbols are used by a Physical Broadcast Channel, PBCH, in 12 contiguous resource blocks, RBs. Optionally, within each of the resource block RB in an OFDM symbol used by PBCH, there are 12 resource elements, and, optionally, 3 of the 12 resource elements are used for a downlink modulation reference signal, DMRS.
    Type: Grant
    Filed: March 26, 2020
    Date of Patent: December 10, 2024
    Assignee: Telefonaktiebolaget LM Ericsson (Publ)
    Inventors: Xingqin Lin, Stefan Parkvall, Yi-Pin Eric Wang
  • Patent number: 12166719
    Abstract: A method performed by a User Equipment (UE) for handling a Control Resource Set (CORESET) from a network node in a wireless communications network is provided. The UE operates with a reduced bandwidth. The UE detects a CORESET from the network node, and that a bandwidth of the CORESET is larger than the bandwidth of the UE. Physical Downlink Control Channel (PDCCH) candidates are transmitted in the CORESET. The UE determines which part of the CORESET to skip, to make the bandwidth of the CORESET equal or smaller than the bandwidth of the UE, such that the UE is capable of receiving the CORESET. The part of the CORESET to be skipped is determined based on a predicted decoding performance of the PDCCH candidates in the CORESET.
    Type: Grant
    Filed: May 18, 2022
    Date of Patent: December 10, 2024
    Assignee: Telefonaktiebolaget LM Ericsson (Publ)
    Inventors: Mohammad Mozaffari, Yi-Pin Eric Wang, Kittipong Kittichokechai, Mehrnaz Afshang, Yutao Sui, Zhilan Xiong, Saeedeh Moloudi
  • Publication number: 20240374737
    Abstract: Described are the bifunctional compounds, compositions and methods of treating a disease or disorder characterized by aberrant extracellular-signal-regulated kinase 5 (ERK5) activity.
    Type: Application
    Filed: September 19, 2022
    Publication date: November 14, 2024
    Applicant: DANA-FARBER CANCER INSTITUTE, INC.
    Inventors: Inchul You, Eric Wang, Nathanael S. Gray
  • Publication number: 20240376096
    Abstract: The present application provides bifunctional compounds that act as protein degradation inducing moieties for cyclin-dependent kinase 4 (CDK4), cyclin-dependent kinase 6 (CDK6) and Ikaros Family Zinc Finger 2 (IKZF2), also known as Helios. Also disclosed are methods for the treatment of disorders modulated by CDK4, CDK6, and IKZF2.
    Type: Application
    Filed: July 15, 2022
    Publication date: November 14, 2024
    Applicant: DANA-FARBER CANCER INSTITUTE, INC.
    Inventors: Alyssa Verano, Eric Wang, Inchul You, Nathanael Gray
  • Patent number: 12139554
    Abstract: Compounds for targeting and agents for imaging, prostate-specific membrane antigen (PSMA) are disclosed. Methods of synthesizing compounds and imaging agents, as well as methods for imaging PSMA are also disclosed. The imaging agents disclosed are suitable for PET and SPECT imaging.
    Type: Grant
    Filed: August 21, 2020
    Date of Patent: November 12, 2024
    Assignee: Siemens Medical Solutions USA, Inc.
    Inventors: Eric Wang, Hartmuth C. Kolb, Anna Katrin Szardenings, Changhui Liu, Joseph C. Walsh, Gang Chen, Anjana Sinha, Dhanalakshmi Kasi, Chul Yu, Umesh B. Gangadharmath, Wei Zhang, Tieming Zhao, Vani P. Mocharla
  • Patent number: 12122851
    Abstract: Compounds for targeting and agents for imaging, prostate-specific membrane antigen (PSMA) are disclosed. Methods of synthesizing compounds and imaging agents, as well as methods for imaging PSMA are also disclosed. The imaging agents disclosed are suitable for PET and SPECT imaging.
    Type: Grant
    Filed: August 21, 2020
    Date of Patent: October 22, 2024
    Assignee: Siemens Medical Solutions USA, Inc.
    Inventors: Eric Wang, Hartmuth C. Kolb, Anna Katrin Szardenings, Changhui Liu, Joseph C. Walsh, Gang Chen, Anjana Sinha, Dhanalakshmi Kasi, Chul Yu, Umesh B. Gangadharmath, Wei Zhang, Tieming Zhao, Vani P. Mocharla
  • Patent number: 12107778
    Abstract: Disclosed is a method for scheduling transmissions of multiple carriers from a single transmitting network node (10; 100) for multiple Narrow Band Internet of Things (NB-IoT) cells, (50). The multiple carriers comprising a respective cell specific anchor carrier having NB-IoT sub-frames allocated for the transmission of mandatory information related to the functionality of the specific cell. The method comprises scheduling (S1) at least two cell specific anchor carriers using time interleaved transmissions that enables NB-IoT sub-frames belonging to different cell specific anchor carriers, and being allocated for the transmission of the mandatory information, to be transmitted at non-overlapping times.
    Type: Grant
    Filed: May 3, 2019
    Date of Patent: October 1, 2024
    Assignee: TELEFONAKTIEBOLAGET LM ERICSSON (PUBL)
    Inventors: Olof Liberg, Yi-Pin Eric Wang
  • Patent number: 12081472
    Abstract: A wireless device (12) is configured for use in a wireless communication system (10). The wireless device (12) is configured to receive signaling (16) from a network node (14). The signaling (16) in some embodiments indicates that a reference signal (20) is configured to be transmitted before and/or during every L occurrence of a physical downlink control channel search space (18), wherein L?2. In other embodiments, the signaling (16) indicates that a reference signal (20) is configured to be transmitted before and/or during every K discontinuous reception, DRX, cycle (22), wherein K?2.
    Type: Grant
    Filed: August 8, 2019
    Date of Patent: September 3, 2024
    Assignee: Telefonaktiebolaget LM Ericsson (publ)
    Inventors: Yi-Pin Eric Wang, Kazuyoshi Uesaka, Santhan Thangarasa, Ritesh Shreevastav, Yutao Sui, Olof Liberg
  • Patent number: 12082117
    Abstract: A network node is configured to monitor battery usage on behalf of the low power device and to predict the SOC and remaining life-time for the batteries in the low power devices. The network nodes are fully powered and have the computational capacity to use more complex and accurate models that are not feasible for implementation in resource-limited devices. The network node can calculate the SOC and remaining life-time for a low power device and may also change the transmission and reception patterns for the device to extend the life-time of the battery.
    Type: Grant
    Filed: May 21, 2019
    Date of Patent: September 3, 2024
    Assignee: Telefonaktiebolaget LM Ericsson (publ)
    Inventors: Talha Khan, Per Gunningberg, Olof Liberg, Yi-Pin Eric Wang